Biomarin Pharmaceutical (BMRN) EPS (Basic) (2009 - 2026)
Biomarin Pharmaceutical's (BMRN) quarterly EPS (Basic) came in at $0.55 in Q1 2026, down 43.62% YoY from $0.97 in Q1 2025, and up 325.75% on a QoQ basis from -$0.24 in Q4 2025.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EPS (Basic) (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 18 years of EPS (Basic) data on file, last reported at $0.55 in Q1 2026.
- Quarterly EPS (Basic) fell 43.62% year-over-year to $0.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 (down 49.11% YoY) and the FY2025 annual result came in at $1.82, down 19.01% from the prior year.
- EPS (Basic) rose to $0.55 in Q1 2026, from -$0.24 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.25 in Q2 2025 to a low of -$0.24 in Q4 2025.
- A 5-year average of $0.37 and a median of $0.3 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 8170.86% — and 2025, when it sank 136.93%.
- Tracing BMRN's EPS (Basic) over 5 years: stood at -$0.0 in 2022, then surged by 8170.86% to $0.11 in 2023, then surged by 506.14% to $0.66 in 2024, then plunged by 136.93% to -$0.24 in 2025, then soared by 325.75% to $0.55 in 2026.
- The last three EPS (Basic) figures came in at $0.55 (Q1 2026), -$0.24 (Q4 2025), and -$0.16 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Biomarin Pharmaceutical | 12.88 Bn | 12.01 Bn | 786.91 Mn | 0.23 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.23 |
| Mar 31, 2026 | 0.55 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | 1.25 |
| Mar 31, 2025 | 0.97 |
| Dec 31, 2024 | 0.66 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.56 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.66 |
| Dec 31, 2021 | -0.32 |
| Sep 30, 2021 | -0.20 |